GHK-Cu Reconstitution Chart (Every Vial Size)

Introduction & Reconstitution Principles for GHK-Cu

GHK-Cu (Glycyl-L-histidyl-L-lysine copper complex) is a widely studied tripeptide-copper complex utilized extensively in preclinical research. Investigators evaluate GHK-Cu primarily for its role in extracellular matrix (ECM) modulation, specifically regarding collagen and elastin synthesis, skin remodeling, wound closure dynamics, and the suppression of fibrotic scarring. Because preclinical protocol designs require exact molar or milligram concentrations, accurate reconstitution of lyophilized GHK-Cu powder is a foundational laboratory requirement.

Reconstitution is the process of dissolving a dry, lyophilized peptide cake into a sterile liquid vehicle—typically Bacteriostatic Water (0.9% benzyl alcohol) or Sterile Water for Injection—to yield a solution of known concentration. Achieving exact concentration metrics demands careful attention to initial vial mass, added diluent volume, and complete dissolution kinetics. PX1 Research supplies high-purity GHK-Cu manufactured in USA-based, GMP-compliant facilities to ensure consistent lyophilized cake mass and predictable solubility across all experimental runs.

To review full analytical validation data or select specific mass specifications for your laboratory, explore our catalog of research peptides or inspect the target-specific GHK-Cu product page. Researchers requiring custom volumes or automated volumetric modeling can also utilize our interactive peptide reconstitution calculator for instant mathematical verification.

GHK-Cu Master Reconstitution Reference Table

The following master reference table provides exact concentration outputs (expressed in mg/mL) and per-0.1 mL volumetric equivalents for standard GHK-Cu research vial sizes (20 mg, 50 mg, and 100 mg) across standard diluent volumes (1.0 mL, 2.0 mL, 3.0 mL, and 5.0 mL). These values assume complete solute dissolution and uniform liquid distribution.

Vial Size: 20 mg | Diluent Added: 1.0 mL | Concentration: 20.0 mg/mL | Mass per 0.1 mL: 2.0 mg Vial Size: 20 mg | Diluent Added: 2.0 mL | Concentration: 10.0 mg/mL | Mass per 0.1 mL: 1.0 mg Vial Size: 20 mg | Diluent Added: 3.0 mL | Concentration: 6.67 mg/mL | Mass per 0.1 mL: 0.67 mg Vial Size: 20 mg | Diluent Added: 5.0 mL | Concentration: 4.0 mg/mL | Mass per 0.1 mL: 0.40 mg

Vial Size: 50 mg | Diluent Added: 1.0 mL | Concentration: 50.0 mg/mL | Mass per 0.1 mL: 5.0 mg Vial Size: 50 mg | Diluent Added: 2.0 mL | Concentration: 25.0 mg/mL | Mass per 0.1 mL: 2.5 mg Vial Size: 50 mg | Diluent Added: 3.0 mL | Concentration: 16.67 mg/mL | Mass per 0.1 mL: 1.67 mg Vial Size: 50 mg | Diluent Added: 5.0 mL | Concentration: 10.0 mg/mL | Mass per 0.1 mL: 1.0 mg

Vial Size: 100 mg | Diluent Added: 1.0 mL | Concentration: 100.0 mg/mL | Mass per 0.1 mL: 10.0 mg Vial Size: 100 mg | Diluent Added: 2.0 mL | Concentration: 50.0 mg/mL | Mass per 0.1 mL: 5.0 mg Vial Size: 100 mg | Diluent Added: 3.0 mL | Concentration: 33.33 mg/mL | Mass per 0.1 mL: 3.33 mg Vial Size: 100 mg | Diluent Added: 5.0 mL | Concentration: 20.0 mg/mL | Mass per 0.1 mL: 2.0 mg

When performing serial dilutions or preparing culture media treatments, researchers should select the diluent volume that provides the most manageable pipetting volume for their specific analytical apparatus. Lot-specific mass tolerance records for PX1 peptides can be verified directly using our lot-specific COA database.

Mathematical Formula for Reconstitution Calculations

Calculating peptide concentration in aqueous solution relies on basic volumetric and mass relationship equations. The fundamental formula determining the final concentration (C) of a reconstituted peptide solution is:

Concentration (mg/mL) = Total Peptide Mass (mg) / Volume of Diluent Added (mL)

To calculate the total mass contained within a specific aliquot volume (V_aliquot) drawn from the reconstituted stock solution, use the following product equation:

Mass per Aliquot (mg) = Concentration (mg/mL) × Aliquot Volume (mL)

For example, if a researcher requires a target concentration expressed in micromolar (µM) for cell culture assays, the mass concentration (mg/mL) must be converted using the molecular weight of the GHK-Cu complex (MW ≈ 403.94 g/mol for GHK-Cu monohydrate/free base variations). The formula for molar concentration is:

Molar Concentration (mM) = Concentration (mg/mL) / Molecular Weight (g/mol) × 1000

Precision measurement at every stage ensures that in vitro assays testing fibroblast migration or gene expression cascades remain statistically robust and reproducible across experimental iterations.

Worked Example 1: Reconstituting a 20 mg GHK-Cu Vial with 2 mL Diluent

Consider a laboratory scenario where a researcher intends to set up a preliminary scratch wound assay using a 20 mg vial of high-purity GHK-Cu research powder. The experimental protocol calls for a stock concentration that allows simple micropipetting into cell culture media.

Step 1: Identify the variables. Total peptide mass (M) = 20 mg. Added diluent volume (V) = 2.0 mL of sterile Bacteriostatic Water.

Step 2: Apply the primary equation. Concentration = 20 mg / 2.0 mL = 10.0 mg/mL.

Step 3: Determine aliquot mass values. If the liquid handling system draws a standard 0.1 mL (100 µL) volume, the mass delivered is calculated as: 10.0 mg/mL × 0.1 mL = 1.0 mg of GHK-Cu.

This 10.0 mg/mL stock solution is ideal for mid-range working stocks. Because GHK-Cu exhibits excellent solubility in aqueous solvents, a 10 mg/mL concentration dissolves rapidly upon gentle swiriling without requiring sonication or intense agitation.

Worked Example 2: Reconstituting a 50 mg GHK-Cu Vial with 5 mL Diluent

In higher-throughput preclinical screening models involving multiple cell culture plates or extended timeline studies, larger mass units such as 50 mg GHK-Cu vials are frequently utilized.

Step 1: Identify the variables. Total peptide mass (M) = 50 mg. Added diluent volume (V) = 5.0 mL.

Step 2: Apply the primary equation. Concentration = 50 mg / 5.0 mL = 10.0 mg/mL.

Step 3: Evaluate lower-volume aliquots. If the assay protocol requires dispensing 0.05 mL (50 µL) into individual assay wells, the target mass delivered per well is: 10.0 mg/mL × 0.05 mL = 0.5 mg (500 µg) of GHK-Cu.

Using 5.0 mL of diluent in a 50 mg vial yields the same 10.0 mg/mL concentration as the 20 mg / 2 mL configuration, demonstrating how scaling diluent proportionally maintains standardized concentration across varying research scales.

Solubility Dynamics and Diluent Selection for In Vitro Assays

Selecting the correct diluent is critical when reconstituting GHK-Cu for laboratory research. Because GHK-Cu is a hydrophilic tripeptide bound to a divalent copper cation (Cu2+), it displays high aqueous solubility under neutral to slightly acidic conditions.

Bacteriostatic Water (containing 0.9% benzyl alcohol) is the standard liquid vehicle for multi-use stock vials retained under refrigeration over multi-day assay periods. The preservative inhibits bacterial proliferation without altering peptide stability. For short-term in vitro cell culture studies where benzyl alcohol could induce cellular toxicity, sterile Phosphate-Buffered Saline (PBS, pH 7.4) or unpreserved Sterile Water for Injection should be substituted.

Preclinical observations indicate that strong alkaline environments (pH > 8.0) or strong chelating agents (such as high EDTA concentrations) can strip the bound copper ion from the peptide matrix, altering both the structural integrity and biological activity of the compound. Consequently, buffer selection must preserve the complexed copper state.

Comparative Analysis: GHK-Cu vs. Related Research Compounds

When designing tissue remodeling and cellular matrix experiments, principal investigators frequently compare GHK-Cu against other signaling peptides and tissue repair candidates. Understanding structural and operational differences ensures the correct compound selection for specific pathway targets.

While GHK-Cu is widely studied for its ability to stimulate collagen Type I/III synthesis and downregulate pro-inflammatory cytokines, AHK-Cu is an alanine-substituted copper tripeptide derivative primarily investigated in specialized hair follicle endothelial models. Conversely, non-copper-binding signaling peptides such as Epithalon operate via telomerase-associated gene regulation pathways rather than extracellular matrix remodeling mechanisms. Furthermore, synthetic gastric peptide fragments like BPC-157 are evaluated for angiogenic and connective tissue healing dynamics through distinct growth factor expression cascades. For expansive cross-category studies, laboratories can establish bulk lab accounts to maintain unified reagent lots across comparative trial arms.

Handling, Storage, and Solution Stability Protocols

Lyophilized GHK-Cu powder exhibits high thermal stability when stored sealed in a desiccated environment. Upon receipt from PX1 Research, dry vials should be stored at -20°C for long-term archival stability or 2°C to 8°C for immediate short-term use.

Following reconstitution, liquid solutions should be kept refrigerated at 2°C to 8°C and protected from direct light exposure, as UV radiation can accelerate peptide backbone degradation. Stock solutions prepared in unpreserved sterile water or PBS should be aliquoted into single-use polypropylene tubes and frozen at -20°C or -80°C to avoid repeated freeze-thaw cycles, which induce physical shear stress and peptide aggregation.

Researchers can review broader storage protocols, solubility charts, and handling guides within the PX1 peptide research hub.

Analytical Verification: HPLC, MS, and Endotoxin Standards at PX1 Research

To ensure reproducible data across in vitro and animal models, research compounds must meet strict purity and identity benchmarks. PX1 Research subjects every lot of GHK-Cu to rigorous analytical verification prior to distribution.

Each batch undergoes High-Performance Liquid Chromatography (HPLC) to confirm purity levels exceeding 99.0%, alongside Mass Spectrometry (MS) to verify molecular weight and exact chemical structure. Furthermore, because bacterial contaminants severely impair cell culture viability and induce artifactual inflammatory responses, PX1 enforces strict endotoxin testing using Limulus Amebocyte Lysate (LAL) assays. All products are manufactured in USA-based, GMP-compliant facilities and tested by independent ISO 17025 accredited laboratories. Every shipment originates from our CA or AZ fulfillment facilities with same-day shipping offered Monday through Friday.